Amarin Corporation PLC Research and Development Expense of Revenue

Research and Development Expense of Revenue of AMRN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development Expense of Revenue for the quarter ending June 30, 2022 was 9.08% (a -7.35% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development Expense of Revenue increased by 83.06%
  • Annual Research and Development Expense of Revenue for 2021 was 4.54% (a -24.46% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2020 was 6.01% (a -22.95% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2019 was 7.8% (a -67.63% decrease from previous year)
  • Twelve month Research and Development Expense of Revenue ending June 30, 2022 was 6.27% (a 25.15% increase compared to previous quarter)
  • Twelve month trailing Research and Development Expense of Revenue increased by 24.65% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
6.27% 5.01% 4.62% 5.03%
Visit stockrow.com/AMRN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development Expense of Revenue of Amarin Corporation PLC

Most recent Research and Development Expense of Revenueof AMRN including historical data for past 10 years.

Interactive Chart of Research and Development Expense of Revenue of Amarin Corporation PLC

Amarin Corporation PLC Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 9.08% 9.8%
2021 3.44% 4.96% 3.61% 6.6% 4.54%
2020 5.09% 6.52% 7.37% 6.63% 6.01%
2019 7.75% 7.94% 7.07% 9.88% 7.8%
2018 15.4% 25.44% 34.49% 26.78% 24.1%
2017 22.18% 22.58% 30.27% 31.25% 25.65%
2016 26.3% 41.21% 37.99% 53.75% 38.42%
2015 50.11% 60.94% 67.82% 79.17% 62.46%
2014 75.46% 102.18% 93.03% 106.75% 92.85%
2013 164.26% 200.18% 317.98% 932.85% 276.08%
2012 0.0% 0.0% 0.0% 0.0% 0.0%
2011 0.0% 0.0% 0.0%

Business Profile of Amarin Corporation PLC

Sector: Healthcare
Industry: Biotechnology